CompoAtlas

Hong Ji Tong Anshen Buxin Wan

Natural health product licensed in Canada

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Salvia miltiorrhiza

Source : Racine

50 mgNot calculated
Schisandra chinensis

Source : Fruit

25 mgNot calculated
Acorus gramineus

Source : Racine

16.7 mgNot calculated
Albizia julibrissin

Source : Écorce (tige)

Extract : Matériel brut sec

Extraction ratio : 18.548:1

Dry plant equivalent : 57.5 mg

3.1 mgNot calculated
Cuscuta chinensis

Source : New material

Extract : Matériel brut sec

Extraction ratio : 18.548:1

Dry plant equivalent : 57.5 mg

3.1 mgNot calculated
Eclipta prostrata

Source : Sommité

Extract : Matériel brut sec

Extraction ratio : 18.548:1

Dry plant equivalent : 57.5 mg

3.1 mgNot calculated
Reynoutria multiflora

Source : Tige

Extract : Matériel brut sec

Extraction ratio : 18.686:1

Dry plant equivalent : 95.3 mg

5.1 mgNot calculated
Rehmannia glutinosa

Source : Tubercule

Extract : Matériel brut sec

Extraction ratio : 18.85:1

Dry plant equivalent : 37.7 mg

2 mgNot calculated
Cristaria plicata

Source : Shell

Extract : Matériel brut sec

Extraction ratio : 18.375:1

Dry plant equivalent : 377.6 mg

20.55 mgNot calculated
Ligustrum lucidum

Source : Fruit

Extract : Matériel brut sec

Extraction ratio : 18.78:1

Dry plant equivalent : 77 mg

4.1 mgNot calculated

Non-medicinal ingredients

pectinase

PopulationAgeQuantity per servingFrequency
AdultesNot specified15 Pilule3 days

Uses authorised in Canada

Text supplied in English because no French text is available.

Used in Traditional Chinese Medicine to help relieve the Yin-blood deficiency symptoms of cardiac palpitation, insomnia, dizziness and tinnitus.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Product record

Other names
Anshen Buxin Pill, Anshen Buxin Wan, Hong Ji Tong Anshen Buxin Pill
Licence holder
ShanDong Hong JI Tang Pharmaceutical Co. Ltd.
NPN or DIN-HM
80081836
Status
Active licence
Licence date
12 December 2017
Revision date
Not provided
Form
Pilule
Route of administration
Orale
Application type
Traditionnelle

Source

Official Health Canada record, licence 80081836

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Hong Ji Tong Anshen Buxin Wan (ShanDong Hong JI Tang Pharmaceutical Co. Ltd.): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80081836-hong-ji-tong-anshen-buxin-wan, updated 12 December 2017.

Enter to analyse, Shift+Enter for a new line